Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-25-000827
Filing Date
2025-01-10
Accepted
2025-01-10 16:01:48
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4/A form4.html 4/A  
1 FORM 4/A form4.xml 4/A 3323
  Complete submission text file 0001140361-25-000827.txt   4952
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12730 HIGH BLUFF DRIVE SUITE 250 SAN DIEGO CA 92130
Business Address
Ma Songjiang (Reporting) CIK: 0001985547 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51173 | Film No.: 25522824